G Merlino, L Fratticci, M Valente, A Del … - Sleep, 2007 - pubmedcentral.nih.gov To look for an association between restless legs syndrome (RLS) and type 2
diabetes in a case-control study; to analyze the characteristics of RLS in
diabetic patients; and to identify possible risk factors for the ... Cited by 26 - Related articles - BL Direct - All 9 versions
JL Kitzmiller, JM Block, FM Brown, PM … - Diabetes Care, 2008 - care.diabetesjournals.org.p.angrylapdog.com This document presents consensus panel recommendations for the medical care of
pregnant women with preexisting diabetes, including type 1 and type 2 diabetes.
The intent is to help clinicians deal with the broad spectrum of problems ... Cited by 26 - Related articles - BL Direct - All 5 versions
SM Sweitzer, SA Fann, TK Borg, JW Baynes, … - The Diabetes Educator, 2006 - tde.sagepub.com From the Department of Surgery (Dr Fann, Dr Yost); the Department of
Pharmacology, Physiology, and Neuroscience (Dr Sweitzer); the Department of Cell
and Developmental Biology and Anatomy (Dr Borg); and the Department of ... Cited by 18 - Related articles - BL Direct - All 3 versions
S Morbach, E Müller, H Reike, A Risse, M … - Diabetes und Stoffwechsel, 2004 - mdb.aezq.de Page 1. Evidenzbasierte Diabetes-Leitlinie DDG – Diabetisches Fußsyndrom,
Update 2008 1 Diagnostik, Therapie, Verlaufskontrolle ... Cited by 51 - Related articles - View as HTML - All 10 versions
SH Horowitz - Current Opinion in Anesthesiology, 2006 - journals.lww.com Recent findings: The demonstration of neuropathic dysfunction in patients with
prediabetes or impaired glucose tolerance emphasizes the susceptibility of
peripheral nerve fibers, especially small A delta fibers and C fibers, to ... Cited by 11 - Related articles - BL Direct - All 3 versions
- ►prsjournal.com [PDF] M Walker, O Ni - American journal of clinical oncology, 2007 - journals.lww.com The development of neurotoxicity during antineoplastic therapy is one of the
most common reasons for termination or modification of cancer treatment. A
number of different agents have been proposed to provide neuroprotection ... Cited by 10 - Related articles - BL Direct - All 4 versions
CJ Currie, CD Poole, A Woehl, CL Morgan, S … - Diabetologia, 2006 - Springer Page 1. ARTICLE The health-related utility and health-related quality of
life of hospital-treated subjects with type 1 or type 2 ... Cited by 8 - Related articles - BL Direct - All 4 versions
DS Oyer, D Saxon, A Shah - Endocrine Practice, 2007 - AACE Diabetic peripheral neuropathy (DPN), the most com- mon of the diabetic
neuropathies, is estimated to be pres- ent in up to 50% of patients with
diabetes (1,2). One of the most common forms of DPN is distal sensory ... Cited by 5 - Related articles - BL Direct - All 2 versions
J Jurado, J Ybarra, JM Pou - Nursing Clinics of North America, 2007 - Elsevier Frequently, DPN diagnosis was viewed solely as a risk factor for foot
ulceration, which limited the interventions to prevent possible injuries. More
recently, modifiable DPN risk factors, such as metabolic control of ... Cited by 4 - Related articles - All 2 versions
